[Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].

Takenobu Katagiri; Jyunji Kamizono; Yasuharu Nakashima; Hiroshi Kitoh; Takafumi Susami; Nobuhiko Haga

[Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].

Takenobu Katagiri, Jyunji Kamizono, Yasuharu Nakashima, Hiroshi Kitoh, Takafumi Susami, Nobuhiko Haga

外科学

研究成果: ジャーナルへの寄稿 › 総説 › 査読

1 被引用数 (Scopus)

抄録

Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic bone formation in skeletal muscle tissue. In 2007, FOP was authorized as one of the Intractable Disorders by the Ministry of Health, Labour and Welfare of Japan. The Research Committee on FOP is working on the molecular mechanisms underlying heterotopic bone formation and the development of new treatments for FOP.

本文言語	英語
ページ（範囲）	1510-1517
ページ数	8
ジャーナル	Clinical calcium
巻	20
号	10
出版ステータス	出版済み - 10月 2010

!!!All Science Journal Classification (ASJC) codes

医学（全般）

他のファイルとリンク

引用スタイル

@article{72ba184822364bb38446d0a6622e40c5,

title = "[Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].",

abstract = "Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic bone formation in skeletal muscle tissue. In 2007, FOP was authorized as one of the Intractable Disorders by the Ministry of Health, Labour and Welfare of Japan. The Research Committee on FOP is working on the molecular mechanisms underlying heterotopic bone formation and the development of new treatments for FOP.",

author = "Takenobu Katagiri and Jyunji Kamizono and Yasuharu Nakashima and Hiroshi Kitoh and Takafumi Susami and Nobuhiko Haga",

year = "2010",

month = oct,

language = "English",

volume = "20",

pages = "1510--1517",

journal = "Clinical calcium",

issn = "0917-5857",

publisher = "Iyaku (Medicine & Drug) Journal Co",

number = "10",

}

TY - JOUR

T1 - [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].

AU - Katagiri, Takenobu

AU - Kamizono, Jyunji

AU - Nakashima, Yasuharu

AU - Kitoh, Hiroshi

AU - Susami, Takafumi

AU - Haga, Nobuhiko

PY - 2010/10

Y1 - 2010/10

N2 - Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic bone formation in skeletal muscle tissue. In 2007, FOP was authorized as one of the Intractable Disorders by the Ministry of Health, Labour and Welfare of Japan. The Research Committee on FOP is working on the molecular mechanisms underlying heterotopic bone formation and the development of new treatments for FOP.

AB - Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic bone formation in skeletal muscle tissue. In 2007, FOP was authorized as one of the Intractable Disorders by the Ministry of Health, Labour and Welfare of Japan. The Research Committee on FOP is working on the molecular mechanisms underlying heterotopic bone formation and the development of new treatments for FOP.

UR - http://www.scopus.com/inward/record.url?scp=79952197256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952197256&partnerID=8YFLogxK

M3 - Review article

C2 - 20890033

AN - SCOPUS:79952197256

VL - 20

SP - 1510

EP - 1517

JO - Clinical calcium

JF - Clinical calcium

SN - 0917-5857

IS - 10

ER -

[Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].

抄録

!!!All Science Journal Classification (ASJC) codes

他のファイルとリンク

フィンガープリント

引用スタイル